CFO4Life Group LLC Purchases New Holdings in Cigna Group $CI

CFO4Life Group LLC acquired a new position in Cigna Group (NYSE:CI) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,254 shares of the health services provider’s stock, valued at approximately $745,000.

Other large investors have also recently made changes to their positions in the company. Retirement Systems of Alabama boosted its stake in shares of Cigna Group by 3.9% during the 2nd quarter. Retirement Systems of Alabama now owns 165,487 shares of the health services provider’s stock worth $54,707,000 after acquiring an additional 6,155 shares during the last quarter. Modern Wealth Management LLC raised its holdings in Cigna Group by 91.3% in the 1st quarter. Modern Wealth Management LLC now owns 3,130 shares of the health services provider’s stock worth $1,030,000 after purchasing an additional 1,494 shares during the period. Janney Montgomery Scott LLC lifted its position in Cigna Group by 3.9% during the second quarter. Janney Montgomery Scott LLC now owns 35,943 shares of the health services provider’s stock valued at $11,882,000 after purchasing an additional 1,357 shares in the last quarter. Acadian Asset Management LLC grew its holdings in Cigna Group by 277.5% during the first quarter. Acadian Asset Management LLC now owns 8,274 shares of the health services provider’s stock valued at $2,718,000 after purchasing an additional 6,082 shares during the period. Finally, Pzena Investment Management LLC grew its holdings in Cigna Group by 9.7% during the second quarter. Pzena Investment Management LLC now owns 523,600 shares of the health services provider’s stock valued at $173,092,000 after purchasing an additional 46,140 shares during the period. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Cigna Group

In other news, CEO David Cordani purchased 4,134 shares of the business’s stock in a transaction on Monday, November 3rd. The stock was acquired at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the acquisition, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This represents a 2.69% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the sale, the insider directly owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.70% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE:CI opened at $269.52 on Friday. The firm has a market cap of $72.00 billion, a price-to-earnings ratio of 14.71, a P/E/G ratio of 0.88 and a beta of 0.44. The firm has a fifty day moving average price of $289.75 and a 200 day moving average price of $301.38. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $69.57 billion for the quarter, compared to the consensus estimate of $66.40 billion. During the same period in the previous year, the firm posted $7.51 EPS. Cigna Group’s revenue for the quarter was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, sell-side analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be paid a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio is presently 26.64%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on CI. UBS Group set a $294.00 price objective on Cigna Group in a research report on Wednesday. Barclays decreased their target price on shares of Cigna Group from $383.00 to $300.00 and set an “overweight” rating on the stock in a research note on Friday, October 31st. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Cigna Group in a report on Monday, November 3rd. Leerink Partners reduced their price objective on shares of Cigna Group from $300.00 to $270.00 in a research note on Friday, October 31st. Finally, Sanford C. Bernstein decreased their price objective on shares of Cigna Group from $346.00 to $294.00 and set a “market perform” rating on the stock in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and an average price target of $334.05.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.